Cell-Matrix Regulation of Fibrochondrocytes In TMJ OA
Cell-Matrix Regulation of Fibrochondrocytes In TMJ OA
批准号:
10214992
负责人:
David Andrew Reed
金额:
$43.29万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2021-03-31
关键词:
AddressAffectAntigensApoptosisArthritisAttenuatedAutophagocytosisBindingBiochemicalBioreactorsCartilageCartilage DiseasesCell DeathCellsChondrocytesClinicalCollagen Type VICytoprotectionDataDegenerative polyarthritisEarly InterventionExposure toExtracellular MatrixFRAP1 geneFibroblastsFlow CytometryFunctional disorderGoalsHealthHumanImmunohistochemistryImpairmentInflammatoryInjuryJointsKnock-outKnockout MiceKnowledgeLimb structureLinkMaintenanceMandibleMechanicsMediatingMicroinjectionsModelingMolecularMonoclonal AntibodiesMonoclonal Antibody TherapyNeuronsOperative Surgical ProceduresOutcomePainPathogenesisPathologyPathway interactionsPatientsPopulationProcessProteoglycanProteolysisQuality of lifeRegulationReplacement ArthroplastyReportingResearchReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionStressTNF geneTemporomandibular JointTemporomandibular Joint DisordersTemporomandibular Joint Dysfunction SyndromeTemporomandibular joint arthritisTemporomandibular joint osteoarthritisTestingTreatment EfficacyWestern BlottingWorkbasecartilage degradationcostdesignin vivoinnovationjoint injuryjoint mobilizationmouse modelnovelnovel therapeutic interventionpre-clinicalreceptorresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Cell-matrix regulation of fibrochondrocytes in TMJ OA
Disorders of the temporomandibular joint (TMJ) affect between 3-7% of the population and osteoarthritis (OA)
is the most common pathology associated with TMJ dysfunction. TMJ OA is a disease of cartilage
degeneration and chondrocyte apoptosis. One of the key factors leading to chondrocyte apoptosis is the
suppression of the cytoprotective process of autophagy. Autophagy is one of the earliest cellular responses to
TMJ OA and has been shown to be a viable therapeutic target for attenuating the progression of cartilage
degeneration. A major gap in knowledge is how mechanical and inflammatory stress leads to the eventual
suppression of autophagy, apoptosis, and cartilage degeneration. To address this gap, my lab has developed
expertise in a preclinical, surgical induction mouse model of TMJ OA that closely corresponds to the human
condition and identified a three-step pathogenesis model linking mechanical damage to ECM changes and
chondrocyte apoptosis that includes 1) the depletion of Collagen VI (Col VI) following surgically-induced TMJ
OA 2) the proteolysis of a Col VI chondrocyte receptor, Neuron/Glial antigen 2 (NG2) and 3) the reduction of
autophagy. The overall goal of our study is to test the hypothesis that injury-induced Col VI degeneration
activates an NG2-dependent pathway that accelerates TMJ cartilage degeneration by suppressing autophagy.
Based on the preliminary data included in this application, we have designed a research plan to
mechanistically define how NG2 binding with Col VI is necessary for the maintenance of autophagy and how
NG2 monoclonal antibody therapy can attenuate the progression TMJ cartilage degradation by protecting
autophagy. The proposed work is innovative because it focuses on a novel molecular mechanism of
chondrocyte function that contextually links matrix dysfunction with loss of a cytoprotective cellular mechanism
implicated in the progression of TMJ OA. The significance of this research lies in the potential application to the
clinical problems of TMJ OA and represents a leap forward in our knowledge of TMJ OA pathophysiology. We
anticipate that the outcomes of our study will inform new therapeutic approaches that attenuate the
progression of TMJ OA and restore TMJ health in patients that would otherwise require alloplastic total joint
replacement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA
-
批准号:10596064
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2021
-
负责人:David Andrew Reed
-
依托单位:
Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA
-
批准号:10209687
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2021
-
负责人:David Andrew Reed
-
依托单位:
Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA
-
批准号:10368995
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2021
-
负责人:David Andrew Reed
-
依托单位:
Chondrocyte-pericellular matrix derived signaling maintains tissue integrity in the temporomandibular joint
-
批准号:9762079
-
项目类别:
-
资助金额:$15.99万
-
财政年份:2018
-
负责人:David Andrew Reed
-
依托单位:
海外基金